尖锐湿疣患者miR-26a和TLR4表达及临床特征与高危型HPV感染的关联

Association of miR-26a and TLR4 expression in patients with condyloma acuminatum and their clinical characteristics with high-risk HPV infection

  • 摘要:
    目的 探讨尖锐湿疣患者微小核糖核酸(miR)-26a、Toll样受体4(TLR4)表达, 临床特征与高危型人乳头瘤病毒(HPV)感染的关联。
    方法 选取2023年7月-2024年6月于武汉第一医院治疗的尖锐湿疣患者103例设为研究组, 获取其疣体组织, 同时选取50名同期健康体检者皮肤组织, 设为对照组。检测两组组织miR-26a、TLR4表达水平并进行比较。检测研究组HPV感染情况, 收集患者临床病理特征, 分析miR-26a、TLR4水平与患者临床特征的关系;依据是否感染高危型HPV分为高危组(n=51)与低危组(n=52), 绘制受试者工作特征(ROC)曲线分析疣体组织miR-26a、TLR4对高危型HPV感染的预测价值。
    结果 研究组疣体组织miR-26a、TLR4水平分别为(2.21±0.64)、(11.41±2.23), 高于对照组(1.31±0.43、7.16±2.11)(P<0.05);不同性别、年龄、皮损位置、疣体数量尖锐湿疣患者疣体组织中miR-26a、TLR4表达水平差异无统计学意义;不同病程、疣体大小、高危型HPV感染的尖锐湿疣患者疣体组织中miR-26a、TLR4表达水平差异有统计学意义(P<0.05)。ROC曲线结果显示, miR-26a、TLR4与两项联合检测曲线下面积分别为0.762、0.743、0.905, 均对尖锐湿疣患者感染高危型HPV具有良好预测价值(P<0.05)。
    结论 尖锐湿疣组织miR-26a、TLR4蛋白均呈异常表达, 且对高危型HPV感染具有良好的预测作用, 可作为尖锐湿疣治疗的生物学指标与靶点。

     

    Abstract:
    OBJECTIVE To investigate the association of microRNA-26a (miR-26a), Toll-like receptor 4 (TLR4) expression in patients with condyloma acuminatum and their clinical characteristics with high-risk human papillomavirus (HPV) infection.
    METHODS A total of 103 patients with condyloma acuminatum treated at Wuhan No. 1 Hospital from Jul. 2023 to Jun. 2024 were enrolled as the study group, and their wart tissues were collected. Additionally, skin tissues from 50 healthy individuals undergoing physical examinations during the same period were selected as the control group. The expression levels of miR-26a and TLR4 in both groups were measured and compared. HPV infection status in the study group was detected, clinicopathological characteristics of patients were collected and their relationship was analyzed. Based on high-risk HPV infection status, patients were divided into a high-risk group (n=51) and a low-risk group (n=52). Receiver operating characteristic (ROC) curves were plotted to evaluate the predictive value of miR-26a and TLR4 in wart tissues for high-risk HPV infection.
    RESULTS The levels of miR-26a and TLR4 in wart tissues of the study group were (2.21±0.64) and (11.41±2.23), respectively, significantly higher than those in the control group (1.31±0.43 and 7.16±2.11, respectinely) (P < 0.05). No statistically significant differences in the expression level of miR-26a and TLR4 were observed in the wart tissues from patients with condyloma acuminatum, regardless of genders, ages, lesion locations or wart numbers; however, significant differences were found among those with different disease durations, wart sizes and high-risk HPV infection status (P < 0.05). ROC curve analysis revealed that the areas under the curve (AUC) for miR-26a, TLR4 and their combined detection were 0.762, 0.743 and 0.905, respectively, indicating good predictive value for high-risk HPV infection in patients with condyloma acuminatum (P < 0.05).
    CONCLUSIONS Both miR-26a and TLR4 protein are abnormally expressed in condyloma acuminatum tissues and demonstrate good predictive potential for high-risk HPV infection, suggesting their utility as biological markers and therapeutic targets for condyloma acuminatum.

     

/

返回文章
返回